1. Home
  2. LNTH vs MMSI Comparison

LNTH vs MMSI Comparison

Compare LNTH & MMSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LNTH
  • MMSI
  • Stock Information
  • Founded
  • LNTH 1956
  • MMSI 1987
  • Country
  • LNTH United States
  • MMSI United States
  • Employees
  • LNTH N/A
  • MMSI N/A
  • Industry
  • LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • MMSI Medical/Dental Instruments
  • Sector
  • LNTH Health Care
  • MMSI Health Care
  • Exchange
  • LNTH Nasdaq
  • MMSI Nasdaq
  • Market Cap
  • LNTH 6.8B
  • MMSI 5.0B
  • IPO Year
  • LNTH 2015
  • MMSI 1990
  • Fundamental
  • Price
  • LNTH $101.98
  • MMSI $96.58
  • Analyst Decision
  • LNTH Strong Buy
  • MMSI Strong Buy
  • Analyst Count
  • LNTH 8
  • MMSI 9
  • Target Price
  • LNTH $125.86
  • MMSI $98.00
  • AVG Volume (30 Days)
  • LNTH 715.5K
  • MMSI 423.1K
  • Earning Date
  • LNTH 10-31-2024
  • MMSI 10-24-2024
  • Dividend Yield
  • LNTH N/A
  • MMSI N/A
  • EPS Growth
  • LNTH 1157.80
  • MMSI 30.66
  • EPS
  • LNTH 6.07
  • MMSI 2.01
  • Revenue
  • LNTH $1,438,011,000.00
  • MMSI $1,301,256,000.00
  • Revenue This Year
  • LNTH $19.64
  • MMSI $8.80
  • Revenue Next Year
  • LNTH $8.77
  • MMSI $6.58
  • P/E Ratio
  • LNTH $16.79
  • MMSI $48.04
  • Revenue Growth
  • LNTH 27.83
  • MMSI 8.60
  • 52 Week Low
  • LNTH $50.20
  • MMSI $62.58
  • 52 Week High
  • LNTH $126.89
  • MMSI $98.02
  • Technical
  • Relative Strength Index (RSI)
  • LNTH 48.04
  • MMSI 69.29
  • Support Level
  • LNTH $102.11
  • MMSI $93.27
  • Resistance Level
  • LNTH $109.60
  • MMSI $96.99
  • Average True Range (ATR)
  • LNTH 4.47
  • MMSI 1.62
  • MACD
  • LNTH -0.01
  • MMSI 0.21
  • Stochastic Oscillator
  • LNTH 42.65
  • MMSI 81.67

About LNTH Lantheus Holdings Inc.

Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.

About MMSI Merit Medical Systems Inc.

Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for use in interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment. The United States generates the majority of the revenue.

Share on Social Networks: